During the past decade, Center for Inflammatory Disease conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Center for Inflammatory Disease" are "Arthritis, Rheumatoid" (4 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Center for Inflammatory Disease" in a lesser frequency.

Most popular intervention types in "Center for Inflammatory Disease" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "BI 695501" (2 trials), "BI 695500" (1 trials), "Clazakizumab" (1 trials), "MabThera®" (1 trials) and "Placebo (Matching with Clazakizumab)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Inflammatory Disease" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Center for Inflammatory Disease". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Center for Inflammatory Disease, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Inflammatory Disease, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".